Headlines
-
Opioid-harm on the rise
Friday | Sep 20 2019PRESCRIPTION medications including codeine, oxycodone and tramadol, are fuelling a surge in hospitalisations linked to opioid-related harm, new research reveals.
-
Qld to get RTPM in 2020
Thursday | Sep 19 2019REAL-TIME prescription monitoring (RTPM) will be introduced in Queensland in the second half of next year, the State's Minister for Health and Ambulance Services, Steven Miles, says.
-
Cost barrier to cannabis
Thursday | Sep 19 2019QUEENSLAND One Nation Senator, Malcolm Roberts, stirred the medicinal cannabis debate in parliament this week claiming the Federal Minister for Health, Greg Hunt, is playing a "pharmaceutical game" with the medicine.
-
Misterhood raises $1.3m
Thursday | Sep 19 2019PRICELINE Pharmacy's Misterhood for the Sisterhood fundraising campaign has raised close to $1.3 million for five charities.
-
Ownership rules appear antiquated
Wednesday | Sep 18 2019INVESTMENT advisory firm, KordaMentha, believes the growth of pharmacy banner groups and franchises is making "the current restrictions on ownership and location appear increasingly antiquated".
-
Don’t waste FWC’s time
Wednesday | Sep 18 2019A PHARMACIST who lodged an unfair dismissal claim against her employer has been chastised for wasting the Fair Work Commission's time, by failing to prosecute the case appropriately.
-
Tassie discounter robbed
Wednesday | Sep 18 2019A WOMAN armed with a syringe threatened staff during an armed robbery in a Hobart pharmacy on Sat afternoon.
-
Ownership has its pitfalls: Lawyers
Tuesday | Sep 17 2019WOULD-BE pharmacy owners are being encouraged to do due diligence before signing a partnership agreement to buy a stake in a pharmacy.
-
Purdue files bankruptcy
Tuesday | Sep 17 2019OXYCONTIN manufacturer, Purdue Pharma, has filed for bankruptcy after agreeing to settle claims relating to its promotion of opioids, for US$10 billion, last week.
-
$100k fine for “excessive dispensing”
Monday | Sep 16 2019AUTHORITIES in Victoria have ordered a pharmacist to pay a fine of $100,000 plus costs of over $10,000 in relation to the ongoing supply of Schedule 4 items on fraudulently altered prescriptions.
